5,600! That is the number of associates across the globe at the Novartis Institutes for BioMedical Research (NIBR). This division is the innovation engine of Novartis, focusing on powerful new technologies that have the potential to help produce breakthroughs for patients. The Next Generation Diagnostics (NGDx) group in NIBR Oncology Translational Research applies cutting-edge technologies and analytical approaches to thousands of oncology clinical trial samples each year and brings hypotheses from biomarker discovery to bear on drug discovery and development.
The NGDx group is seeking a creative and motivated scientist with expertise in cancer genetics, genomics, and molecular biology. This role will advance our translational research efforts via the development of novel approaches, as well as the identification and evaluation of external technologies, to further our understanding of cancer biology. The successful candidate will be an effective communicator, an engaged collaborator, and have a deep scientific curiosity.
Your Responsibilities Will Include:
• Development of novel diagnostic assays using innovative molecular biology techniques and analysis approaches
• Independent identification and development of creative solutions to scientific questions
• Collaboration on the applications of diagnostic technologies to enable exploratory biomarker discovery in a range of oncology clinical settings
• Maintaining currency with both academic and industry advancements in relevant technology areas
Diversity & Inclusion / EEO
The Novartis Group of Companies are Equal Opportunity Employers and take pride in maintaining a diverse environment. We do not discriminate in recruitment, hiring, training, promotion or other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, gender identity or expression, marital or veteran status, disability, or any other legally protected status. We are committed to building diverse teams, representative of the patients and communities we serve, and we strive to create an inclusive workplace that cultivates bold innovation through collaboration and empowers our people to unleash their full potential.
What you'll bring to the role:
• PhD or equivalent training, 3-5 years of postdoctoral training preferred
• Solid understanding of genomics and cancer genetics
• Track record of peer-reviewed publications that apply new technologies/approaches to understand cancer biology
• Demonstrated statistical and analytical ability. Programming proficiency in R desired
• Strong verbal and written communication skills, excellent organizational and interpersonal skills
• Proficiency in experimental design, data analysis and interpretation
WHY CONSIDER NOVARTIS?
799 million. That's how many lives our products touched in 2019. And while we're proud of that fact, in this world of digital and technological transformation, we must also ask ourselves this: how can we continue to improve and extend even more people's lives?
We believe the answers are found when curious, courageous and collaborative people like you are brought together in an inspiring environment. Where you're given opportunities to explore the power of digital and data. Where you're empowered to risk failure by taking smart risks, and where you're surrounded by people who share your determination to tackle the world's toughest medical challenges.
Imagine what you could do at Novartis!
Commitment to Diversity & Inclusion:
Novartis embraces diversity, equal opportunity and inclusion. We are committed to building diverse teams, representative of the patients and communities we serve, and we strive to create an inclusive workplace that cultivates bold innovation through collaboration, and empowers our people to unleash their full potential.
Join our Novartis Network: If this role is not suitable to your experience or career goals but you wish to stay connected to learn more about Novartis and our career opportunities, join the Novartis Network here: https://talentnetwork.novartis.com/network
Company / Legal Entity
Research & Development